We seek to further advance the CHRCDA at UCLA. We have leveraged substantial institutional support, a world-class research infrastructure, a cadre of leading mentors experienced in training pediatricians with >$100,000,000/yr of NIH grants, and the unique diversity of our University and its interdisciplinary environment, in order to foster the transition of our scholars to successful independent research careers. Chair of Pediatrics, Sherin Devaskar, MD, previously the Scientific Director of the UCLA CHRCDA, is the Principal Investigator, in concert with the Training Director, Pinchas Cohen, MD. A recruitment and diversity officer will administer the program, which will also be regularly reviewed by external advisors. Over the last 15 years, the UCLA CHRCDA has recruited over thirty outstanding scholars, many of whom were women and minorities, who have initiated transition to independent careers in basic and translational research relevant to children's health. These scholars amassed substantial achievements and subsequent funding of over $60,000,000. New candidates for our program will be UCLA Pediatric junior faculty, appointed from an impressive cohort of pediatricians enrolled in our subspecialty fellowships, or recruited through national searches for excellence and promise. Measures to attract women and minority applicants will be incorporated into the recruitment process. Each candidate will identify a prospective mentor from a group of 46 mentors chosen for their superb scientific and training abilities in areas relevant to children's health. Their projects will be tailored to meet the scholars'subspecialty interests and mentors'expertise, and will address basic/translational aspects of pediatric disease. Four pediatric scholars will be competitively selected each year and each will typically be supported for two years. They will have ready access to a comprehensive array of research core facilities, and will engage in both formal course training in research methodologies and informal on-going mentoring sessions. Each scholar will have a mentoring committee, which will interact with the Program Director and Training Director to ensure that the career development plan is individualized and implemented. Regular scholarly activities that are included in the CHRCDA program include both extensive University-wide ongoing educational activities, as well as several weekly CHRCDA pediatric-specific research lecture series. A key priority of the program will continue to be monitoring and tracking of the program as a whole, of the performance of the mentors, and of the progress of the scholars, and will be achieved through regular reviews, audits, advisory meetings, and systematic on-line data collection and analysis. Given the new dynamic leadership of the UCLA CHRCDA, its superb faculty mentors, outstanding institutional facilities, extensive curricular structure, formal selection and evaluatin processes and emphasis on recruiting women and minorities, we expect this program to enable us to substantially advance our goal of continuing our strong track record of producing independent investigators performing cutting-edge child health research.

Public Health Relevance

Childhood health and diseases continues to represent a national priority and cause significant suffering and death globally and locally. In addition, many diseases of aging have their beginnings in childhood, making investment in research on pediatric topics an important goal for ensuring health throughout the lifetime. There is a critical need to advance the science related to childhood diseases, and translate basic research findings into novel interventions to improve the health of Americans of all ages. A group of renowned mentors with extensive research and training expertise will educate outstanding young pediatric physician scientists embarking on careers in academic medicine in how to conduct basic and translational research of importance to children, toward the goals of improving our knowledge of pediatric diseases and discovering novel treatments.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12HD034610-17
Application #
8383442
Study Section
Special Emphasis Panel (ZHD1-DSR-N (53))
Program Officer
Winer, Karen
Project Start
2002-02-15
Project End
2016-11-30
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
17
Fiscal Year
2013
Total Cost
$370,941
Indirect Cost
$32,000
Name
University of California Los Angeles
Department
Pediatrics
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Calkins, Kara L; Thamotharan, Shanthie; Dai, Yun et al. (2018) Early dietary restriction in rats alters skeletal muscle tuberous sclerosis complex, ribosomal s6 and mitogen-activated protein kinase. Nutr Res 54:93-104
Kuo, Caroline Y; Long, Joseph D; Campo-Fernandez, Beatriz et al. (2018) Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. Cell Rep 23:2606-2616
Chen, Pao-Yang; Chu, Alison; Liao, Wen-Wei et al. (2018) Prenatal Growth Patterns and Birthweight Are Associated With Differential DNA Methylation and Gene Expression of Cardiometabolic Risk Genes in Human Placentas: A Discovery-Based Approach. Reprod Sci 25:523-539
Gell, Joanna J; Zhao, Jasmine; Chen, Di et al. (2018) PRDM14 is expressed in germ cell tumors with constitutive overexpression altering human germline differentiation and proliferation. Stem Cell Res 27:46-56
Kuo, Caroline Y; Garcia-Lloret, Maria I; Slev, Patricia et al. (2017) Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screening. J Allergy Clin Immunol Pract 5:198-200
Williams, Carmen J; Chu, Alison; Jefferson, Wendy N et al. (2017) Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency. J Pathol 242:246-259
Truscott, Laurel; Gell, Joanna; Chang, Vivian Y et al. (2017) Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation. Pediatr Blood Cancer 64:100-102
Ha, V L; Luong, A; Li, F et al. (2017) The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation. Leukemia 31:2503-2514
Hanudel, Mark R; Salusky, Isidro B (2017) Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder. Curr Osteoporos Rep 15:198-206
Upadhyay, Shivani Y; De Oliveira, Satiro N; Moore, Theodore B (2017) Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report. J Investig Med High Impact Case Rep 5:2324709617728528

Showing the most recent 10 out of 58 publications